Mary Ann Pelleymounter

Title: Mary Ann Pelleymounter: Innovator in OB Protein Compositions

Introduction

Mary Ann Pelleymounter is a prominent inventor based in San Diego, CA. She has made significant contributions to the field of biotechnology, particularly in the development of OB protein compositions. With a total of 5 patents to her name, her work focuses on methods that enhance lean tissue mass and improve metabolic health.

Latest Patents

Pelleymounter's latest patents include innovative methods for increasing lean tissue mass using OB protein compositions. These patents describe DNA sequences that encode fusion proteins, which consist of an Fc portion of an antibody attached to an OB protein moiety. The inventions also cover vectors and host cells that utilize these DNA sequences, as well as processes for preparing the fusion proteins. The pharmaceutical compositions derived from these innovations are aimed at providing therapeutically effective amounts for various health benefits, such as increasing insulin sensitivity, controlling serum glucose levels, and enhancing overall body strength.

Career Highlights

Throughout her career, Mary Ann Pelleymounter has worked with notable companies in the biotechnology sector, including Amgen Inc. and Amylin Pharmaceuticals, Inc. Her expertise in OB protein research has positioned her as a key figure in the development of treatments for metabolic disorders.

Collaborations

Pelleymounter has collaborated with esteemed colleagues, including Michael B Mann and Christopher Francis Toombs. These partnerships have furthered her research and contributed to the advancement of her patented technologies.

Conclusion

Mary Ann Pelleymounter's innovative work in OB protein compositions has the potential to transform treatments for metabolic health. Her contributions to biotechnology continue to pave the way for advancements in therapeutic applications.